Effect of Biolimus-Eluting Stents With B...

Medicaid provides health insurance for 1 in 5 Americans and plays a crucial role in US health care infrastructure. The One Big Beautiful Bill Act (OBBBA) is estimated to cut Medicaid spending by nearly $1 trillion by 2034 and cause millions of enrollees to lose coverage. In this ... Show More

GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and ... Show More

The United States has witnessed a staggering rise in obesity beginning in the early 1980s, leading to a wide array of important health consequences including heart disease, diabetes, and premature death. In this episode of Healthy Dialogue, Host Derek C. Angus, MD, MPH, talks wit ... Show More

Dr. Linda Chu speaks with Dr. Daniele Andreini about the Advantage II Study, which evaluates the accuracy of dynamic stress myocardial CT perfusion in patients with coronary artery stents. They discuss how this technique compares to invasive testing, its advantages over static CT ... Show More

In this episode, Dr. Valentin Fuster discusses the findings of a major randomized trial examining the use of drug-coated balloons (DCB) in treating side branch stenosis during coronary bifurcation procedures. The study suggests that DCBs offer better one-year outcomes compared to ... Show More

In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space. Guest: Dr. DeRubertis, is the ... Show More

<p>ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to comment, visi ... Show More

Dr. Seemant Chaturvedi discusses AtRial Cardiopathy and Antithrombotic Drugs in Prevention after Cryptogenic Stroke Randomized Trial [ARCADIA]. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. 

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative diagnostic tool of 3D Printing – What are the clinical uses? Limitations? Research findings and future ... Show More

What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event? Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s feat ... Show More

Today, on the Nutrition Facts podcast, we look at stents — those tiny tubes that doctors insert into a blocked artery to keep it open. This episode features audio from Do Angioplasty Heart Stent Procedures Work? and Why Angioplasty Heart Stents Don’t Work Better. Visit the video ... Show More

<p>When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals on ... Show More